AI in Clinical Trials Market Growth: Expected CAGR of 22.4 % Driven by Demand in Cardiovascular diseases, Immunology disease, Infecstious disease, Metabolic diseases Analysis, Market Trends, and Growth Overview Report 2023 - 2030

AI in Clinical Trials Market Scope:
Market size value in 2023 - USD 1.59 Billion
Market size value in 2030 - USD 6.55 Billion
CAGR (2023-2030) - 22.4 %
Forecast Period - 2023-2030
Segments Covered - Offering, Technology, Application, End User & Region.
Geographies Covered - North America, Europe, Asia Pacific, and Row
Sample of Companies Covered - BioAge Labs, Inc., Symphony AI., Median Technologies, Innoplexus, Antidote Technologies, Inc., GNS Healthcare, Koneksa Health, Halo Health Systems, and DEEP LENS AI.

Download Sample Pages-https://www.marketdigits.com/request/sample/3813

Browse in-depth TOC on "AI in Clinical Trials Market"
178-Tables
95-Figures
332-Pages

North America dominates the market for AI in Clinical Trials.
North America exhibits dominant influence in the AI in clinical trials market. The region's leadership is attributed to several factors, including a robust healthcare infrastructure, significant investments in research and development, and the presence of leading pharmaceutical and biotech companies. Moreover, the regulatory environment in North America is conducive to the adoption of innovative technologies, providing a favorable landscape for AI integration in clinical trials. The region benefits from a wealth of data sources and collaborations between technology firms and healthcare institutions, facilitating the development and implementation of AI solutions. The emphasis on precision medicine and personalized healthcare further propels the demand for AI in clinical trials, positioning North America at the forefront of advancements in this rapidly evolving field.

Ask for Discount- https://www.marketdigits.com/request/discount/3813

Top Key Players Covered in the Report-
IBM Corporation, Exscientia, Saama Technologies, Unlearn.AI, Inc., BioSymetrics, Euretos, Trials.Ai, Insilico Medicine, Ardigen, Pharmaseal, Koninklijke Philips N.V., Intel, Numerate, AiCure, LLC, Envisagenics, NURITAs, BioAge Labs, Inc., Symphony AI., Median Technologies, Innoplexus, Antidote Technologies, Inc., GNS Healthcare, Koneksa Health, Halo Health Systems, and DEEP LENS AI. and Others

For More Information - Inquire Now!
https://www.marketdigits.com/request/enquiry-before-buying/3813

Recent Developments-
August 2023, Texas Tech University Health Sciences Center has partnered with Deep 6 AI to initiate an AI program focused on clinical trials. This collaboration aims to leverage artificial intelligence to enhance and streamline processes within the clinical trial domain.

https://industrytoday.co.uk/market-research-industry-today/emerging-trends-and-innovations-for-the-ai-in-clinical-trials-market-projected-to-reach-usd-655-billion-by-2030

MarketDigits
Email: sales@marketdigits.com

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

This release was published on openPR.